Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-16T13:30:14.173Z Has data issue: false hasContentIssue false

6 - Variation in psychotropic responses in the Chinese population

Published online by Cambridge University Press:  22 August 2009

Tian-Mei Si
Affiliation:
Institute of Mental Health, Peking University Beijing, China
Chee H. Ng
Affiliation:
University of Melbourne
Keh-Ming Lin
Affiliation:
National Health Research Institutes, Taiwan
Bruce S. Singh
Affiliation:
University of Melbourne
Edmond Y. K. Chiu
Affiliation:
University of Melbourne
Get access

Summary

Psychopharmacotherapy in the Chinese population

Traditional medicine, especially herbal medicine and acupuncture, has a long history in China. Included in the voluminous classic literature of traditional Chinese medicine are specific acupuncture procedures and a large number of herbal formulas that have been regarded as useful for the treatment of mental disorders. Although most of these methods have not yet been examined with rigorous clinical trials, it does appear that, in general, they are likely to be effective in the treatment of mood disorders, but not psychotic disorders. Systematic settings to provide care for the severely mentally ill started in late nineteenth century. The first European styled mental hospital was established in Guangzhou, China, in 1898. Gradually more mental hospitals were established in other large cities in China. However, until the introduction of chlorpromazine in the 1950s, therapeutic options were extremely limited, and traditional Chinese medicine therapy, insulin coma, and electro-convulsive therapy (ECT) were commonly used for the treatment of severely disturbed patients.

As is true worldwide, the arrival of the phenothiazines in the 1950s heralded a new era for the treatment of psychotic disorders in China. The earliest antipsychotic medications used included rauwolfiae, reserpine, promazine, and acetylpromazine. In 1956, domestic chlorpromazine was produced in Shanghai. Based on open clinical trials and descriptive clinical case observations, the clinical profiles of these potent agents, including their efficacy and tolerability, were established in the Chinese populations.

Type
Chapter
Information
Ethno-psychopharmacology
Advances in Current Practice
, pp. 87 - 96
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

An, B. F., Zhang, M. L. & Qi, S. G. (2006). Comparative study between the effect of olanzapine and quetiapine in first-episode schizophrenia. Chinese Journal of Clinical Psychiatry, 16(2), 84–5.Google Scholar
Chen, J., Lu, Z., Jiang, S. D.et al. (2005). Association between polymorphism in the cytochrome P450 enzymes 1A2 2C19 gene and treatment-resistant depression. Shanghai Archive of Psychiatry, 17(2), 95–8.Google Scholar
Chen, J. D., Guo, X. F., Xue, Z. M.et al. (2006). A randomized and double blind positive control clinical trial of bupropion SR for the treatment of depression. Chinese Journal of New Drugs, 15(5), 379–82.Google Scholar
Chen, L. X., Wang, Z. G., Ai, M.et al. (2005). Effect of CYP2C19 genotypes on demethylation of amitriptyline in Chinese patients with depression. Chinese Journal of Nervous and Mental Diseases, 31(1), 33–6.Google Scholar
Fu, Q. L., Huang, F., Wu, D. Z.et al. (2005). Analyses of the phenotype polymorphism of cytochrome CYP2C19 in Chinese Han. Chinese Journal of New Drugs, 14(4), 461–4.Google Scholar
Fu, Y., Fan, C. H., Zhao, Z. H.et al. (2006a). Association of CYP2D6 gene C188T polymorphism with tardive dyskinesia (TD) in Chinese patients with schizophrenia. Chinese Journal of Behavioral Medicine, 15(1), 36–7.Google Scholar
Fu, Y., Fan, C. H., Deng, H. H.et al. (2006b). Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients. Acta Pharmacol Sin, 27(3), 328–32.Google Scholar
Han, X. M., Chen, X. P., Wu, Q. N.et al. (2000). G-2964A and C734A genetic polymorphisms of CYP1A2 in Chinese population. Acta Pharmacologica Sinica, 21, 1031–4.Google Scholar
Hou, Y. Z., Guo, J. H., Zhou, F.et al. (2001). The double-blind study of risperidone and haloperidal in the treatment of schizophrenia. Shanghai Archive of Psychiatry, 13(3), 149–51.Google Scholar
Huang, Y., Ding, H., Wang, W. Z.et al. (2002a). The genetic polymorphisms of CYP2C19 and CYP2C9 in Chinese patients with epilepsy. Journal of Chinese Clinical Medicine, 3(20), 4–6.Google Scholar
Huang, Y., Liu, X. H., Xu, K.et al. (2002b). Association study of cytochrome P450 2D6 gene polymorphism and therapeutic response to risperidone in Chinese subjects with schizophrenia. Journal of Chinese Psychiatry, 35(2), 103–6.Google Scholar
Jiang, R. H., Shu, L., Zhang, H. Y.et al. (2006). A phase II randomized double blind multi-centers and parallel control clinical trial for bupropion SR in the treatment of depressive disorders. Chinese Journal of New Drugs, 15(2), 128–31.Google Scholar
Kong, Q. M., Si, T. M. & Shu, L. (2003). The effects of olanzapine on body weight liver functions blood sugar and cholesterol level. Chinese Journal of New Drugs, 12(10), 847–9.Google Scholar
Li, C., Chu, S. Y., Lin, Z.et al. (2005). A controlled study of olanzapine and haloperidol in the treatment of the acute phrase of schizophrenia. Shanghai Archive of Psychiatry, 17(5), 275–7.Google Scholar
Li, F., Jiang, K. D., Jiang, S. D.et al. (2004). Novel mutation of the cytochrome P450 1A2 gene associated with the clinical response to clozapine in Chinese schizophrenic patients. Shanghai Archive of Psychiatry, 16(3), 136–40.Google Scholar
Li, G. C., Yang, J., Chen, Z. G.et al. (2005). Expression of cytokine and gene polymorphism of CYP2D6 in Han Urghur and Hasake nationality in China. Chinese Journal of Pharmaceuticals, 40(17), 1330–2.Google Scholar
Lin, J. R., Hou, J., Lu, X. Q.et al. (2002a). The relationship between the polymorphism of cytochrome P4502D6 and clinical response of paroxetine in Chinese. The Chinese Journal of Clinical Pharmacology, 18(1), 22–5.Google Scholar
Lin, J. R., Zhen, D.et al. (2002b). Correlation between polymorphism of cytochrome P450 2D6 gene and clinical response to fluoxetine. Journal of Chinese Psychiatry, 35(1), 18–21.Google Scholar
Liu, S. Q., Wang, J. H. & Zhou, H. H. (2000). Pharmacokinetics of fluoxetine and its effects on cytochrome P450 isoenzymes. Acta Pharmacologica Sinica, 16(6), 618–20.Google Scholar
Liu, W. B., Li, H. C., Zhen, L. L.et al. (2004). A controlled study on olanzapine and clozapine in the treatment of the acute phase of schizophrenia. Shanghai Archive of Psychiatry, 16(5), 282–4.Google Scholar
Liu, Z. Q., Shu, Y., Huang, S. L.et al. (2001). Effects of CYP2C19 genotype and CYP2C9 on fluoxetine N-demethylation in human liver microsomes. Acta Pharmacologica Sinica, 22: 85–90.Google Scholar
Qi, X. l., Huang, Y., Wang, Y. Q.et al. (2004). Association of plasma sodium phenytoin concentration with CYP2C19 gene polymorphism. Chinese Journal of New Drugs, 13(10), 922–5.Google Scholar
Shen, Y. F., Li, H. F., Ma, C.et al. (2005). Comparison of reboxetine with fluoxetine in treatment of depression:a randomized double-blind multicenter study. Chinese Journal of New Drugs and Clinical Remedies, 24(8), 619–23.Google Scholar
Shu, Y., Cheng, Z. N., Liu, Z. Q.et al. (2001). Interindividual variations in levels and activities of cytochrome P-450 in liver microsomes of Chinese subjects. Acta Pharmacologica Sinica, 22(3), 283–8.Google Scholar
Si, T. M. & Shu, L. (2006). Open-label study the effects of venlafaxine-XR in the treatment of depression. Chinese Journal of Nervous and Mental Diseases, 32(1), 69–71.Google Scholar
Si, T. M., He, Y. L., Zhou, R. Y.et al. (2003). Psychotropics prescription pattern for the inpatients with schizophrenia. Journal of Chinese Mental Health, 17(10), 705–7.Google Scholar
Si, T. M., Shu, L., Yu, X.et al. (2004a). Antipsychotic drug patterns of schizophrenia in China: a cross sectional study. Chinese Journal of Psychiatry, 37(3), 152–5.Google Scholar
Si, T. M., Shu, L., Yu, X.et al. (2004b). Pharmacoepidemiological investigation on patients with depression in China. Chinese Journal of Nervous and Mental Diseases, 30(2), 81–4.Google Scholar
Si, T. M., Shu, L., Yu, X.et al. (2005a). The efficacy and safety of citalopram in treatment of depression: a multi-center open-label study. Chinese Journal of Psychiatry, 38(4), 222–6.Google Scholar
Si, T. M., Shu, L., Yu, X.et al. (2005b). A cross-sectional study on medication treatment patterns of bipolar disorder in China. Chinese Journal of Psychiatry, 38(3), 165–9.Google Scholar
Si, T. M., Yang, Q., Liu, Y.et al. (2006). The relationship between the genetic polymorphism of CYP P450 2C19 and the pharmacokinetics of escitalopram in Chinese volunteers. Chinese Journal of New Drugs, 15(15), 1296–9.Google Scholar
Tantcheva-Poor, I., Zaigler, M., Rietbrock, S.et al. (1999). Estimation of cytochrome P450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics, 9, 131–44.Google Scholar
Wang, B., Yang, X. M., Jiang, S. D.et al. (2004). Genetic analysis of the cytochrome P450–2D6(CYP2D6) locus: screening influence of risperidone on clinical outcomes in schizophrenia. Shanghai Archive of Psychiatry, 16(4), 199–202.Google Scholar
Wang, C. Y., Zhao, J. P., Chen, Y. G.et al. (2000). The pharmacokinetics of clozapine correlated with a caffeine test. Journal of Chinese Psychiatry, 33(1), 16–18.Google Scholar
Wang, C. Y., Li, W. B., Zhai, Y. M.et al. (2003). Inhibition of olanzapine metabolism in vivo by fluvoxamine: a pharmacokinetic study in man. Journal of Chinese Psychiatry, 36(1), 3–6.Google Scholar
Wang, G., Cai, Z. J., Wang, L. F.et al. (2004). A multicenter study of risperidone treatment for acute agitation in patients with schizophrenia. Journal of Chinese Psychiatry, 37(2), 88–91.Google Scholar
Wang, X. X., Mu, J. S. & Wang, S. H. (2004). Association study of serotonin transporter gene polymorphism and depression. Chinese Journal of Clinical Psychiatry, 14(4), 195–7.Google Scholar
Wang, Y. H., Shi, Z. Y., Zhao, G. Q.et al. (2006). Association between 5-HT2A receptor gene polymorphism and risperidone treatment response in the first episode (drug-naive) Chinese patients with schizophrenia. Chinese Journal of Nervous and Mental Diseases, 32(4), 294–9.Google Scholar
Wu, M. L., Wu, X. H. & Chen, S. C. (2005). Study on tissue distribution difference of cytochrome P450 2C19 in Chinese population Han. Journal of Chinese Pharmaceuticals, 40(3), 215–18.Google Scholar
Wu, Z. L., Huang, S. L., Yang, Ou D. S.et al. (1998). Clomipramine N-demethylation metabolism in human liver microsomes. Acta Pharmacologica Sinica, 19(5), 433–6.Google Scholar
Xu, Z. H., Huang, S. L. & Zhou, H. H. (1996). Inhibition of imipramine N- demethylation by fluvoxamine in Chinese young men. Acta Pharmacologica Sinica, 17(5), 399–402.Google Scholar
Yang, C., Zhao, J. P., Liu, B.et al. (2002). Relationships between clozapine steady-state concentration CYP1A2 activity and clinical response in schizophrenic patients. Journal of Chinese Psychiatry, 35(4), 202–5.Google Scholar
Yao, G. Z., Liu, P. & Shu, L. (1997). An open study on efficacy of a new antidepressant citalopram. Chinese Journal of New Drugs, 6(3), 170–3.Google Scholar
Zhang, H. Y., Shu, L., Li, H. F.et al. (2006). Risperidone versus haloperidol in treatment of acute manic episodes of bipolar I disorder: a randomized double-blind controlled multicenter study. Journal of Chinese Psychiatry, 39(1), 33–7.Google Scholar
Zhang, S., Dong, Z. W., Tang, L.et al. (2002). Cytochrome P450 2C19 gene polymorphism in four Chinese nationality populations. Journal of Chinese Medical Genetics, 19(1), 52–4.Google Scholar
Zhang, X. B., Sha, W. W., Zhang, Z. J.et al. (2005).T102C polymorphism in 5-HT2A receptor gene and tarditive dyskinesia in chronic schizophrenia. Chinese Mental Health Journal, 19(1), 8–10.Google Scholar
Zhao, A. L., Zhao, J. P., Xue, Z. M.et al. (2005). Association between polymorphism in the dopamine D4 receptor gene and qualitative and quantitative characters of schizophrenia in Chinese.Chinese Journal of Psychiatry, 38(1), 3–6.Google Scholar
Zhou, M., Liu, P., Zhang, H. Y.et al. (2002). Double-blind comparison between risperidone and haloperidol in the treatment of schizophrenic patients. Chinese Journal of Clinical Pharmacology, 18(5), 341–4.Google Scholar
Zhu, B., Xu, Z. H., Wang, W.et al. (1999). N-Demethylation of clomipramine in human liver microsomes in vitro. Journal of Chinese Pharmacology and Toxicology, 13(4), 253–9.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×